The goal of this trial is to determine the efficacy of levofloxacin based sequential treatment regimen or concomitant levofloxacin based regimens as empirical first-line therapy in the Syrian population
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
150
amoxicillin 1000 mg bid ,esomprazole 20 bid for one week then levofloxacine 500 mg q.d, metraonidazoel 500 500 bid, and esomprazole 20 bid for one week
Levofloxacin 500 mg qd, amoxicillin 500 2cab bid,Tinadizole 500 bid, esomprazole 20 bid
General Assembly of Damascus Hospital
Damascus, Syria
Eradication rate of Helicobacter pylori infection
Eradication rate of Helicobacter infected patients
Time frame: 8 week from begning of treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.